SCHEMBL1395644

SCHEMBL1395644

O=S(=O)(I)C(F)(F)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.39
CA1 P00915 3/20 0.39
CA7 P43166 1/20 0.39
CA13 Q8N1Q1 1/20 0.39
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
MMP13 P45452 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1395634 0.81
SCHEMBL14472110 0.80
SCHEMBL1395624 0.80 CA2 (0.40) CA2CA1MMP1MMP2MMP9
SCHEMBL1395615 0.78 CA2 (0.50) CA2CA1MMP1MMP2MMP9
SCHEMBL14471880 0.71 CA1 (0.32) CA2CA1CA7CA13
SCHEMBL14471926 0.71 CA1 (0.32) CA2CA1CA7CA13
SCHEMBL776245 0.69 CA2 (0.44) CA2CA1CA7CA13MMP1
SCHEMBL5960786 0.69 CA2 (0.37) CA2CA1CA7CA13MMP1
SCHEMBL24624665 0.67
SCHEMBL24899711 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111051278-B Method for producing perfluoroalkyl sulfimide metal salt 中央硝子株式会社 2022-05-13 CN disclosed
CN-111051278-A Method for producing perfluoroalkyl sulfimide metal salt 中央硝子株式会社 2020-04-21 CN disclosed
CN-107074753-B Method for producing (fluorosulfonyl) perfluoroalkanesulfonylimide salt 中央硝子株式会社 2019-09-06 CN disclosed
EP-2543663-B1 PREPARATION METHOD FOR PERFLUOROALKANE SULFINATE CENTRAL GLASS CO LTD (JP) 2017-10-11 EP disclosed
CN-107074753-A Method for producing (fluorosulfonyl) perfluoroalkanesulfonylimide salt 中央硝子株式会社 2017-08-18 CN disclosed
US-9073828-B2 Preparation method for perfluoroalkane sulfinate CENTRAL GLASS COMPANY, LIMITED (JP) 2015-07-07 US disclosed
EP-2289875-B1 PROCESS FOR PRODUCING PERFLUOROALKANESULFINIC ACID SALT CENTRAL GLASS CO LTD (JP) 2013-04-10 EP disclosed
US-20130023695-A1 Preparation Method for Perfluoroalkane Sulfinate CENTRAL GLASS COMPANY, LIMITED (JP) 2013-01-24 US disclosed
EP-2543663-A1 PREPARATION METHOD FOR PERFLUOROALKANE SULFINATE Central Glass Company, Limited (JP) 2013-01-09 EP disclosed
EP-2289875-A1 PROCESS FOR PRODUCING PERFLUOROALKANESULFINIC ACID SALT Central Glass Company, Limited (JP) 2011-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130023695-A1 Preparation Method for Perfluoroalkane Sulfinate PFAS, PFKFB1, PFKFB2 CA2 306/4885CA1 380/4885CA7 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.